全文获取类型
收费全文 | 4468篇 |
免费 | 285篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 107篇 |
妇产科学 | 82篇 |
基础医学 | 576篇 |
口腔科学 | 79篇 |
临床医学 | 455篇 |
内科学 | 1006篇 |
皮肤病学 | 57篇 |
神经病学 | 531篇 |
特种医学 | 63篇 |
外国民族医学 | 1篇 |
外科学 | 451篇 |
综合类 | 43篇 |
一般理论 | 1篇 |
预防医学 | 404篇 |
眼科学 | 46篇 |
药学 | 364篇 |
中国医学 | 10篇 |
肿瘤学 | 453篇 |
出版年
2023年 | 48篇 |
2022年 | 104篇 |
2021年 | 167篇 |
2020年 | 96篇 |
2019年 | 136篇 |
2018年 | 142篇 |
2017年 | 99篇 |
2016年 | 120篇 |
2015年 | 125篇 |
2014年 | 193篇 |
2013年 | 204篇 |
2012年 | 340篇 |
2011年 | 339篇 |
2010年 | 166篇 |
2009年 | 185篇 |
2008年 | 239篇 |
2007年 | 260篇 |
2006年 | 255篇 |
2005年 | 198篇 |
2004年 | 207篇 |
2003年 | 214篇 |
2002年 | 187篇 |
2001年 | 33篇 |
2000年 | 39篇 |
1999年 | 46篇 |
1998年 | 32篇 |
1997年 | 38篇 |
1996年 | 25篇 |
1995年 | 26篇 |
1994年 | 24篇 |
1993年 | 24篇 |
1992年 | 29篇 |
1991年 | 21篇 |
1990年 | 25篇 |
1989年 | 16篇 |
1988年 | 24篇 |
1987年 | 33篇 |
1986年 | 20篇 |
1985年 | 32篇 |
1984年 | 24篇 |
1983年 | 18篇 |
1982年 | 16篇 |
1981年 | 15篇 |
1979年 | 18篇 |
1978年 | 12篇 |
1977年 | 12篇 |
1974年 | 13篇 |
1972年 | 11篇 |
1969年 | 14篇 |
1968年 | 15篇 |
排序方式: 共有4767条查询结果,搜索用时 15 毫秒
41.
L. D. Bornemann H. E. Spiegel Z. E. Dziewanowska S. E. Krown W. A. Colburn 《European journal of clinical pharmacology》1985,28(4):469-471
Summary Interferon is currently being evaluated for the treatment of disseminated cancer and viral diseases. Alpha interferons have shown to be effective in the treatment of a number of malignancies. Recombinant leukocyte A interferon (rIFN-A) is an alpha interferon produced by recombinant DNA techniques. A kinetic evaluation of rIFN-A following intravenous and intramuscular administration has not been adequately defined. The present study was designed to evaluate the kinetics of rIFN-A following intravenous and intramuscular administration of 3, 9 or 18×106 units to patients with disseminated cancer.A preliminary report of this study was presented at the meeting of the American Society for Clinical Pharmacology and Therapeutics in San Diego, March 1983 (1). 相似文献
42.
Characteristics of very poor outcome schizophrenia 总被引:2,自引:0,他引:2
R S Keefe R C Mohs M F Losonczy M Davidson J M Silverman K S Kendler T B Horvath R Nora K L Davis 《The American journal of psychiatry》1987,144(7):889-895
The authors compared 21 "Kraepelinian" schizophrenic patients who had been ill and dependent on others for the past 5 years with 76 chronic schizophrenic patients in remission or with exacerbations requiring hospitalization. The Kraepelinian patients met the criteria for schizophrenia by more diagnostic systems than the exacerbated patients, were less responsive to haloperidol, had more severe negative symptoms, and had similarly severe positive symptoms. They had cerebral ventricles that were more asymmetrical and a greater family history of schizophrenia spectrum disorders than the other chronic patients. These data suggest that patients with 5 years of illness and complete dependency on others may represent a subgroup of schizophrenia. 相似文献
43.
44.
45.
Joanna Paladino Suzanne Mitchell Namita Mohta Joshua R. Lakin Nora Downey Erik K. Fromme Sue Gullo Evan Benjamin Justin J. Sanders 《Joint Commission journal on quality and patient safety / Joint Commission Resources》2021,47(2):127-136
The COVID-19 pandemic has exposed the medical and social vulnerability of an unprecedented number of people. Consequently, there has never been a more important time for clinicians to engage patients in advance care planning (ACP) discussions about their goals, values, and preferences in the event of critical illness. An evidence-based communication tool—the Serious Illness Conversation Guide—was adapted to address COVID-related ACP challenges using a user-centered design process: convening relevant experts to propose initial guide adaptations; soliciting feedback from key clinical stakeholders from multiple disciplines and geographic regions; and iteratively testing language with patient actors. With feedback focused on sharing risk about COVID-19–related critical illness, recommendations for treatment decisions, and use of person-centered language, the team also developed conversation guides for inpatient and outpatient use. These tools consist of open-ended questions to elicit perception of risk, goals, and care preferences in the event of critical illness, and language to convey prognostic uncertainty. To support use of these tools, publicly available implementation materials were also developed for clinicians to effectively engage high-risk patients and overcome challenges related to the changed communication context, including video demonstrations, telehealth communication tips, and step-by-step approaches to identifying high-risk patients and documenting conversation findings in the electronic health record. Well-designed communication tools and implementation strategies can equip clinicians to foster connection with patients and promote shared decision making. Although not an antidote to this crisis, such high-quality ACP may be one of the most powerful tools we have to prevent or ameliorate suffering due to COVID-19. 相似文献
46.
47.
Weranja Ranasinghe Daniel D. Shapiro Hyunsoo Hwang Xuemei Wang Chad A. Reichard Mohamed Elsheshtawi Mary F. Achim Tharakeswara Bathala Chad Tang Ana Aparicio Shi-Ming Tu Nora Navone Timothy C. Thompson Louis Pisters Patricia Troncoso John W. Davis Brian F. Chapin 《European urology》2021,79(2):298-306
BackgroundDuctal prostate adenocarcinoma (DAC) is a rare, aggressive, histologic variant of prostate cancer that is treated with conventional therapies, similar to high-risk prostate adenocarcinoma (PAC).ObjectiveTo assess the outcomes of men undergoing definitive therapy for DAC or high-risk PAC and to explore the effects of androgen deprivation therapy (ADT) in improving the outcomes of DAC.Design, setting, and participantsA single-center retrospective review of all patients with cT1–4/N0–1 DAC from 2005 to 2018 was performed. Those undergoing radical prostatectomy (RP) or radiotherapy (RTx) for DAC were compared with cohorts of high-risk PAC patients.Outcome measurements and statistical analysisMetastasis-free survival (MFS) and overall survival (OS) rates were analyzed using Kaplan-Meier and Cox regression models.Results and limitationsA total of 228 men with DAC were identified; 163 underwent RP, 34 underwent RTx, and 31 had neoadjuvant therapy prior to RP. In this study, 163 DAC patients and 155 PAC patients undergoing RP were compared. Similarly, 34 DAC patients and 74 PAC patients undergoing RTx were compared. DAC patients undergoing RP or RTx had worse 5-yr MFS (75% vs 95% and 62% vs 93%, respectively, p < 0.001) and 5-yr OS (88% vs 97% and 82% vs 100%, respectively, p < 0.05) compared with PAC patients. In the 76 men who received adjuvant/salvage ADT after RP, DAC also had worse MFS and OS than PAC (p < 0.01). A genomic analysis revealed that 10/11 (91%) DACs treated with ADT had intrinsic upregulation of androgen-resistant pathways. Further, none of the DAC patients (0/15) who received only neoadjuvant ADT prior to RP had any pathologic downgrading. The retrospective nature was a limitation.ConclusionsMen undergoing RP or RTx for DAC had worse outcomes than PAC patients, regardless of the treatment modality. Upregulation of several intrinsic resistance pathways in DAC rendered ADT less effective. Further evaluation of the underlying biology of DAC with clinical trials is needed.Patient summaryThis study demonstrated worse outcomes among patients with ductal adenocarcinoma of the prostate than among high-grade prostate adenocarcinoma patients, regardless of the treatment modality. 相似文献
48.
Julie A. Hides Gunda Lambrecht Christopher T. Sexton Casey Pruett Nora Petersen Patrick Jaekel André Rosenberger Guillaume Weerts 《The spine journal》2021,21(3):477-491
BACKGROUND CONTEXTOne of the primary changes in the neuromuscular system in response to microgravity is skeletal muscle atrophy, which occurs especially in muscles that maintain posture while being upright on Earth. Reduced size of paraspinal and abdominal muscles has been documented after spaceflight. Exercises are undertaken on the International Space Station (ISS) during and following space flight to remediate these effects. Understanding the adaptations which occur in trunk muscles in response to microgravity could inform the development of specific countermeasures, which may have applications for people with conditions on Earth such as low back pain (LBP).PURPOSEThe aim of this study was to examine the changes in muscle size and function of the lumbar multifidus (MF) and anterolateral abdominal muscles (1) in response to exposure to 6 months of microgravity on the ISS and (2) in response to a 15-day reconditioning program on Earth.DESIGNProspective longitudinal series.PATIENT SAMPLEData were collected from five astronauts who undertook seven long-duration missions on the ISS.OUTCOME MEASURESFor the MF muscle, measures included cross-sectional area (CSA) and linear measures to assess voluntary isometric contractions at vertebral levels L2 to L5. For the abdominal muscles, the thickness of the transversus abdominis (TrA), obliquus internus abdominis (IO) and obliquus externus abdominis (EO) muscles at rest and on contraction were measured.METHODSUltrasound imaging of trunk muscles was conducted at four timepoints (preflight, postflight, mid-reconditioning, and post reconditioning). Data were analyzed using multilevel linear models to estimate the change in muscle parameters of interest across three time periods.RESULTSBeta-coefficients (estimates of the expected change in the measure across the specified time period, adjusted for the baseline measurement) indicated that the CSA of the MF muscles decreased significantly at all lumbar vertebral levels (except L2) in response to exposure to microgravity (L3=12.6%; L4=6.1%, L5=10.3%; p<.001), and CSAs at L3-L5 vertebral levels increased in the reconditioning period (p<.001). The thickness of the TrA decreased by 34.1% (p<.017), IO decreased by 15.4% (p=.04), and the combination of anterolateral abdominal muscles decreased by 16.2% (p<.001) between pre- and postflight assessment and increased (TrA<0.008; combined p=.035) during the postreconditioning period. Results showed decreased contraction of the MF muscles at the L2 (from 12.8% to 3.4%; p=.007) and L3 (from 12.2% to 5%; p=.032) vertebral levels following exposure to microgravity which increased (L2, p=.046) after the postreconditioning period. Comparison with preflight measures indicated that there were no residual changes in muscle size and function after the postreconditioning period, apart from CSA of MF at L2, which remained 15.3% larger than preflight values (p<.001).CONCLUSIONSIn-flight exercise countermeasures mitigated, but did not completely prevent, changes in the size and function of the lumbar MF and anterolateral abdominal muscles. Many of the observed changes in size and control of the MF and abdominal muscles that occurred in response to prolonged exposure to microgravity paralleled those seen in people with LBP or exposed to prolonged bed rest on Earth. Daily individualized postflight reconditioning, which included both motor control training and weight-bearing exercises with an emphasis on retraining strength and endurance to re-establish normal postural alignment with respect to gravity, restored the decreased size and control of the MF (at the L3-L5 vertebral levels) and anterolateral abdominal muscles. Drawing parallels between changes which occur to the neuromuscular system in microgravity and which exercises best recover muscle size and function could help health professionals tailor improved interventions for terrestrial populations. Results suggested that the principles underpinning the exercises developed for astronauts following prolonged exposure to microgravity (emphasizing strength and endurance training to re-establish normal postural alignment and distribution of load with respect to gravity) can also be applied for people with chronic LBP, as the MF and anterolateral abdominal muscles were affected in similar ways in both populations. The results may also inform the development of new astronaut countermeasures targeting the MF and abdominal muscles. 相似文献
49.
50.
The history of the Medicare program, including changes that have been enacted over the years in an effort to control spiraling costs, is reviewed. Medigap insurance and preventive medical care for the elderly are examined, as is the impact of Medicare coverage for the terminally ill. Trends indicate that the Medicare system as presently structured is not financially viable. The question is: what will replace it? 相似文献